News
The European Molecular Biology Organisation extends lifetime membership to NCBS scientist Sumantra Chattarji
It is believed that EMBO bestows lifetime membership to only a few selected scientists across the world who have done outstanding work in their respective fields.
European Investment Bank and CureVac sign €75 million loan agreement for development of vaccine candidate against SARS-CoV-2
CureVac’s mRNA technology platform has believed to have shown potential in the clinical development and production of mRNA based vaccines and therapeutics.
National Medicinal Plants Board and ICAR-National Bureau of Plant Genetic Resources ink MoU on plant genetic resource conservation
The purpose of this MoU is to conserve the Medicinal and Aromatic Plants Genetic Resources (MAPGRs) at designated space of ICAR-NBPGR.
Clinical trials for Regeneron's investigational double antibody cocktail for COVID-19 initiated
According to Regeneron, the Phase 3 trial will evaluate REGN-COV2's ability to prevent infection among uninfected people who have had close exposure to a COVID-19 patient
CSIR, Laxai Sciences to seek approval to undertake clinical trials of antiviral and host-directed combination therapies on Covid-19 patients
Dr Shekhar C. Mande has highlighted that this combinatorial strategy (antivirals and HDTs) with repurposed drugs having complementary, additive and synergistic role, has been adopted to increase therapeutic options for Covid-19 treatment.
Exhibit in the 'India Pavilion' at BIO 2026
